Subsequent studies demonstrated that BME treatment modulates the downstream molecules of c-Met signaling pathway, such as, phosphoStat3, c-myc, and Mcl-1 in HNSCC cells. The gene discussed is MCL1; the disease is head and neck squamous cell carcinoma.